SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-23-001916
Filing Date
2023-05-16
Accepted
2023-05-16 14:54:09
Documents
191
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 20-F zk2329547.htm   iXBRL 20-F 7627685
2 EXHIBIT 1.1 exhibit_1-1.htm EX-1.1 1631291
3 EXHIBIT 2.1 exhibit_2-1.htm EX-2.1 22542
4 EXHIBIT 4.17 exhibit_4-17.htm EX-4.17 180067
5 EXHIBIT 12.1 exhibit_12-1.htm EX-12.1 8750
6 EXHIBIT 12.2 exhibit_12-2.htm EX-12.2 8701
7 EXHIBIT 13.1 exhibit_13-1.htm EX-13.1 5657
8 EXHIBIT 13.2 exhibit_13-2.htm EX-13.2 5736
9 EXHIBIT 15.1 exhibit_15-1.htm EX-15.1 8765
  Complete submission text file 0001178913-23-001916.txt   37031403

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE trib-20221231.xsd EX-101.SCH 255691
11 XBRL CALCULATION FILE trib-20221231_cal.xml EX-101.CAL 88564
12 XBRL DEFINITION FILE trib-20221231_def.xml EX-101.DEF 667110
13 XBRL LABEL FILE trib-20221231_lab.xml EX-101.LAB 1856512
14 XBRL PRESENTATION FILE trib-20221231_pre.xml EX-101.PRE 1009787
185 EXTRACTED XBRL INSTANCE DOCUMENT zk2329547_htm.xml XML 9820275
Mailing Address 3 ROCK ROAD SANDYFORD INDUSTRIAL ESTATES DUBLIN IRELAND L2 18
Business Address IDA BUSINESS PARK, BRAY, CO WICKLOW IRELAND DUBLIN IRELAND L2 18 01135312955111
TRINITY BIOTECH PLC (Filer) CIK: 0000888721 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-22320 | Film No.: 23926864
SIC: 2835 In Vitro & In Vivo Diagnostic Substances